DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Dougherty & Co. Upgrades NextGen Healthcare to Buy, Announces $11 Price Target

Dougherty & Co. analyst Gene Mannheimer upgrades NextGen Healthcare (NASDAQ:NXGN) from Neutral to Buy and announces $11 price target.

Benzinga · 03/18/2020 11:51

Dougherty & Co. analyst Gene Mannheimer upgrades NextGen Healthcare (NASDAQ:NXGN) from Neutral to Buy and announces $11 price target.